
### [NCIT:C68700](http://purl.obolibrary.org/obo/NCIT_C68700)
**Label:** Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities

**Subclasses:** [NCIT:C68698](http://purl.obolibrary.org/obo/NCIT_C68698) (Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C68699](http://purl.obolibrary.org/obo/NCIT_C68699) (Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C68696](http://purl.obolibrary.org/obo/NCIT_C68696) (Adult Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C68697](http://purl.obolibrary.org/obo/NCIT_C68697) (Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C9155](http://purl.obolibrary.org/obo/NCIT_C9155) (Adult Acute Promyelocytic Leukemia with PML-RARA), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39584](http://purl.obolibrary.org/obo/NCIT_C39584) (T-Cell Large Granular Lymphocyte Leukemia, Common Variant))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39583](http://purl.obolibrary.org/obo/NCIT_C39583) (FAS Apoptosis Pathway Deregulation))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3958](http://purl.obolibrary.org/obo/NCIT_C3958) (Disseminated Peritoneal Leiomyomatosis))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39573](http://purl.obolibrary.org/obo/NCIT_C39573) (T-Lymphocyte with a Post-Thymic Immunophenotype))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39572](http://purl.obolibrary.org/obo/NCIT_C39572) (Neoplastic Cerebriform T-Prolymphocyte))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39571](http://purl.obolibrary.org/obo/NCIT_C39571) (Neoplastic Small T-Prolymphocyte))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39569](http://purl.obolibrary.org/obo/NCIT_C39569) (Cytoplasmic Protrusions Present))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39565](http://purl.obolibrary.org/obo/NCIT_C39565) (Coarse Azurophilic Granules Present))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3950](http://purl.obolibrary.org/obo/NCIT_C3950) (Oral Mucosa Lobular Capillary Hemangioma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3939](http://purl.obolibrary.org/obo/NCIT_C3939) (Bannayan Syndrome))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39301](http://purl.obolibrary.org/obo/NCIT_C39301) (CD4+/CD56+ Neoplastic Medium-Sized Cell))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39300](http://purl.obolibrary.org/obo/NCIT_C39300) (Precursor Natural Killer Cell))) 38.30%


